Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Common Equity (2016 - 2025)

Aspen Aerogels (ASPN) has disclosed Common Equity for 13 consecutive years, with $305.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity fell 39.77% year-over-year to $305.7 million, compared with a TTM value of $305.7 million through Sep 2025, down 39.77%, and an annual FY2024 reading of $614.7 million, up 25.95% over the prior year.
  • Common Equity was $305.7 million for Q3 2025 at Aspen Aerogels, down from $308.8 million in the prior quarter.
  • Across five years, Common Equity topped out at $614.7 million in Q4 2024 and bottomed at $66.6 million in Q1 2021.
  • Average Common Equity over 5 years is $330.1 million, with a median of $314.8 million recorded in 2025.
  • The sharpest move saw Common Equity surged 248.45% in 2022, then tumbled 40.37% in 2025.
  • Year by year, Common Equity stood at $128.4 million in 2021, then soared by 248.45% to $447.4 million in 2022, then increased by 9.08% to $488.1 million in 2023, then increased by 25.95% to $614.7 million in 2024, then tumbled by 50.26% to $305.7 million in 2025.
  • Business Quant data shows Common Equity for ASPN at $305.7 million in Q3 2025, $308.8 million in Q2 2025, and $314.8 million in Q1 2025.